These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23679955)

  • 1. Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.
    Rempel V; Volz N; Gläser F; Nieger M; Bräse S; Müller CE
    J Med Chem; 2013 Jun; 56(11):4798-810. PubMed ID: 23679955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists.
    Rempel V; Volz N; Hinz S; Karcz T; Meliciani I; Nieger M; Wenzel W; Bräse S; Müller CE
    J Med Chem; 2012 Sep; 55(18):7967-77. PubMed ID: 22916707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.
    Schoeder CT; Kaleta M; Mahardhika AB; Olejarz-Maciej A; Łażewska D; Kieć-Kononowicz K; Müller CE
    Eur J Med Chem; 2018 Jul; 155():381-397. PubMed ID: 29902723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
    Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
    J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
    Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
    J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
    Behrenswerth A; Volz N; Toräng J; Hinz S; Bräse S; Müller CE
    Bioorg Med Chem; 2009 Apr; 17(7):2842-51. PubMed ID: 19278853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
    Anavi-Goffer S; Irving AJ; Ross RA
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.
    Morales P; Whyte LS; Chicharro R; Gómez-Cañas M; Pazos MR; Goya P; Irving AJ; Fernández-Ruiz J; Ross RA; Jagerovic N
    J Med Chem; 2016 Mar; 59(5):1840-53. PubMed ID: 26789378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR evaluation of coumarin derivatives as potent cannabinoid receptor agonists.
    Mohr F; Hurrle T; Burggraaff L; Langer L; Bemelmans MP; Knab M; Nieger M; van Westen GJP; Heitman LH; Bräse S
    Eur J Med Chem; 2021 Aug; 220():113354. PubMed ID: 33915369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Sharir H; Shore DM; Hurst DP; Lynch DL; Madrigal KE; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak LS; Croatt MP; Abood ME; Reggio PH
    Biochemistry; 2013 Dec; 52(52):9456-69. PubMed ID: 24274581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of GPR55 as a lysophosphatidylinositol receptor.
    Oka S; Nakajima K; Yamashita A; Kishimoto S; Sugiura T
    Biochem Biophys Res Commun; 2007 Nov; 362(4):928-34. PubMed ID: 17765871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity.
    Mahardhika AB; Załuski M; Schoeder CT; Boshta NM; Schabikowski J; Perri F; Łażewska D; Neumann A; Kremers S; Oneto A; Ressemann A; Latacz G; Namasivayam V; Kieć-Kononowicz K; Müller CE
    J Med Chem; 2024 Jun; 67(12):9896-9926. PubMed ID: 38885438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.
    Brown AJ; Daniels DA; Kassim M; Brown S; Haslam CP; Terrell VR; Brown J; Nichols PL; Staton PC; Wise A; Dowell SJ
    J Pharmacol Exp Ther; 2011 Apr; 337(1):236-46. PubMed ID: 21233197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
    Sharir H; Abood ME
    Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential changes in GPR55 during microglial cell activation.
    Pietr M; Kozela E; Levy R; Rimmerman N; Lin YH; Stella N; Vogel Z; Juknat A
    FEBS Lett; 2009 Jun; 583(12):2071-6. PubMed ID: 19464294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.
    Balenga NA; Martínez-Pinilla E; Kargl J; Schröder R; Peinhaupt M; Platzer W; Bálint Z; Zamarbide M; Dopeso-Reyes IG; Ricobaraza A; Pérez-Ortiz JM; Kostenis E; Waldhoer M; Heinemann A; Franco R
    Br J Pharmacol; 2014 Dec; 171(23):5387-406. PubMed ID: 25048571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
    Zhao P; Abood ME
    Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.